Benevolent AI (XAMS:BAI) Scaled Net Operating Assets : 0.42 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Benevolent AI's operating assets for the quarter that ended in Dec. 2023 was €101.40 Mil. Benevolent AI's operating liabilities for the quarter that ended in Dec. 2023 was €28.80 Mil. Benevolent AI's Total Assets for the quarter that ended in Jun. 2023 was €173.07 Mil. Therefore, Benevolent AI's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.42.

Benevolent AI Scaled Net Operating Assets Historical Data

The historical data trend for Benevolent AI's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Scaled Net Operating Assets Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.60

0.29

0.21

0.77

0.34

Benevolent AI Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial				-	0.10	0.32	0.38	0.42

Competitive Comparison of Benevolent AI's Scaled Net Operating Assets

For the Biotechnology subindustry, Benevolent AI's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Benevolent AI Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Benevolent AI's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(101.397	-	28.8)	/	213.811
=	0.34

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	143.738	-	42.341
=	101.397

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	34.312	-	4.438	-	1.074
=	28.8

Benevolent AI's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(101.397	-	28.8)	/	173.074
=	0.42

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	143.738	-	42.341
=	101.397

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	34.312	-	4.438	-	1.074
=	28.8

Benevolent AI Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BAIVF:USA 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.